Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. [electronic resource]
Producer: 20051201Description: 362-74 p. digitalISSN:- 0014-4819
- Adenosine A2 Receptor Antagonists
- Animals
- Caffeine -- analogs & derivatives
- Cell Count
- Dynorphins -- biosynthesis
- Enkephalins -- biosynthesis
- Globus Pallidus -- physiology
- Immunohistochemistry
- In Situ Hybridization
- Male
- Microinjections
- Neostriatum -- physiology
- Neural Pathways -- physiology
- Neuroprotective Agents
- Oxidopamine -- administration & dosage
- Parkinson Disease, Secondary -- chemically induced
- Protein Precursors -- biosynthesis
- RNA, Messenger -- biosynthesis
- Rats
- Rats, Sprague-Dawley
- Receptor, Adenosine A2A -- biosynthesis
- Stereotyped Behavior -- drug effects
- Substantia Nigra -- cytology
- Sympatholytics -- administration & dosage
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.